About Xellia Pharmaceuticals
Xellia Pharmaceuticals is a company based in Copenhagen (Denmark) founded in 1903 was acquired by Novo Holdings in May 2013. The company has 52 employees as of April 06, 2024.
- Headquarter Copenhagen, Denmark
- Employees 52 as on 06 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Xellia Pharmaceuticals Private Limited
- Date of Incorporation 13 Sep, 2010
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$2.64 M (USD)22.19as on Mar 31, 2023
-
Net Profit
$254.83 K (USD)24.4as on Mar 31, 2023
-
EBITDA
$472.25 K (USD)5.14as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
52
as on Apr 06, 2024
-
Acquired by
Novo Holdings
(May 21, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Xellia Pharmaceuticals
Unlock access to complete
Unlock access to complete
Leadership Team
13 people
Operations Team
11 people
Software Development Team
10 people
Finance and Accounting
8 people
Human Resources and Administration
7 people
Senior Team
6 people
Sales and Marketing
5 people
Board Team
4 people
Unlock access to complete
Funding Insights of Xellia Pharmaceuticals
Detailed funding history for Xellia Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Xellia Pharmaceuticals
Xellia Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Novo Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked |
Investor details for Xellia Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xellia Pharmaceuticals
Investment portfolio details for Xellia Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Xellia Pharmaceuticals
Detailed financials for Xellia Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xellia Pharmaceuticals Comparisons
Peer comparison for Xellia Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xellia Pharmaceuticals
Detailed competitors of Xellia Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xellia Pharmaceuticals
Complete news archive for Xellia Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xellia Pharmaceuticals
Xellia Pharmaceuticals was founded in 1903.
Xellia Pharmaceuticals is headquartered in Copenhagen, Denmark.
As of Apr 06, 2024, the latest employee count at Xellia Pharmaceuticals is 52.
Annual revenue of Xellia Pharmaceuticals is $2.64M as on Mar 31, 2023.
Founded in 1903 and headquartered in Copenhagen, Denmark, Xellia Pharmaceuticals operates in the pharmaceutical sector with a focus on anti-infective therapies. Active pharmaceutical ingredients are supplied to companies worldwide, while finished dosage forms are provided mainly through contract manufacturing organizations. Research and development, manufacturing, and commercialization activities are conducted, with emphasis placed on sustainable practices for critical care treatments of serious infections.
Xellia Pharmaceuticals has 1 investor. Key investors include Novo Holdings.